Skip to content

Clinical trials

Terminated Alzheimer Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Terminated Country / region: Italy Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20092
20101
20121
20133
20142
20152
20165
20173
20184
20191
20203
20211
20223
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche8
Biogen5
Eli Lilly and Company4
Pfizer4
FORUM Pharmaceuticals Inc3
AstraZeneca2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
AbbVie1
Alector Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease38
Dementia10
Brain Diseases5
Central Nervous System Diseases4
Mental Disorders4
Nervous System Diseases4
Neurocognitive Disorders3
Neurodegenerative Diseases3
Tauopathies3
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.